CTBO (Cantabio Pharmaceuticals) Other Stockholders Equity: $1.06 Mil (As of Dec. 2018)


What is Cantabio Pharmaceuticals Other Stockholders Equity?

Cantabio Pharmaceuticals CTBO Other Stockholders Equity is $1.06 Mil as of Dec. 2018.

Cantabio Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Dec. 2018 was $1.06 Mil.

Cantabio Pharmaceuticals's quarterly Other Stockholders Equity declined from Jun. 2018 ($1.06 Mil) to Sep. 2018 ($1.06 Mil) but then increased from Sep. 2018 ($1.06 Mil) to Dec. 2018 ($1.06 Mil).

Cantabio Pharmaceuticals's annual Other Stockholders Equity increased from Mar. 2016 ($0.50 Mil) to Mar. 2017 ($1.06 Mil) but then declined from Mar. 2017 ($1.06 Mil) to Mar. 2018 ($1.06 Mil).

Cantabio Pharmaceuticals Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Other Stockholders Equity Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Other Stockholders Equity
Get a 7-Day Free Trial -0.00 0.00 0.50 1.06 1.06

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 1.06 1.06 1.06 1.06

Cantabio Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $1.06 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Other Stockholders Equity of $1.06 Mil as of Dec. 2018. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Other Stockholders Equity too high?
Cantabio Pharmaceuticals' current Other Stockholders Equity is $1.06 Mil.
How does Cantabio Pharmaceuticals' Other Stockholders Equity compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Other Stockholders Equity of $1.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Other Stockholders Equity is $1.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Other Stockholders Equity of $1.06 Mil. The current Other Stockholders Equity is $1.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Other Stockholders Equity is $1.06 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.